Trials / Withdrawn
WithdrawnNCT03284021
Fraxel Laser for Alopecia
A Pilot Study on 1550 nm Fractional Erbium-glass Laser for Alopecia Treatment
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a pilot study to evaluate the effect of the 1550 nm fractional erbium-glass laser in patients with nonscarring alopecias. Participants currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment. Participants will receive 5 sessions of laser, 30 days apart, to the area of alopecia on the scalp. Follow-up is at 150 days. This study was a pilot study designed to determine feasibility of this procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fractional erbium-glass 1550 nm laser | The fractional erbium-glass 1550 nm laser will be applied to the previously 100 cm2 determined area of the scalp with the following parameters: 5-10 mm tip, 5-10 mJ, pulse energy 500-1500 MTZ/cm2 density, one to twopasses, static mode. |
Timeline
- Start date
- 2019-04-24
- Primary completion
- 2019-04-24
- Completion
- 2019-04-24
- First posted
- 2017-09-15
- Last updated
- 2021-12-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03284021. Inclusion in this directory is not an endorsement.